Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2

Nature Reviews Cancer

Volumn 1, Issue 1, 2001, Pages 11-21

  Gupta, Rajnish A ^a   DuBois, Raymond N ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ISOENZYME; MEMBRANE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS2 PROTEIN, HUMAN;

ANIMAL; BIOSYNTHESIS; COLORECTAL TUMOR; DISEASE MODEL; DRUG ANTAGONISM; ENZYMOLOGY; HUMAN; PHYSIOLOGY; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RECEPTORS, PROSTAGLANDIN E;

EID: 0035496616     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/35094017     Document Type: Article

References (21)

1. Greenlee, R. T., Murray, T., Bolden, S. & Wingo, P. A. Cancer statistics. 2000. CA Cancer J. Clin. 50, 7-33 (2000).
2. Herschman, H. R. Prostaglandin synthase 2. Biochim. Biophys, Acta 1299, 125-140 (1996).
3. DuBois, R. N. et al. Cyclooxygenase in biology and disease. FASEB J. 12, 1063-1073 (1993).
4. Herschman, H. R., Xie, W. & Reddy, S. Inflammation, reproduction, cancer and all that...: the regulation and role of the inducible prostaglandin synthase. Bioessays 17, 1031-1037 (1995).
5. Smith, W. L., DeWitt, D. L. & Garavito, R. M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69, 145-182 (2000).
6. Raz, A., Wyche, A., Siegel, N. & Needleman, P. Regulation of fibroblast cyclooxygenase synthesis by interleukin-1. J. Biol. Chem. 263, 3022-3028 (1988).
7. Fu, J. Y., Masferrer, J. L., Seibert, K., Raz, A. & Needleman, P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J. Biol. Chem. 265, 16737-16740 (1990).
8. Xie, W., Chipman, J., Robertson, D., Erikson, R. & Simmons, D. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl Acad. Sci. USA 88, 2692-2696 (1991).
9. Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W. & Herschman, H. R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 266, 12866-12872 (1991).
10. Smith, W. L., Garavito, R. M. & DeWitt, D. L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and-2. J. Biol. Chem. 271, 33157-33160 (1996).
11. Masferrer, J. L et al. Selective inhibition of inducible cyclooxygenase-2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl Acad. Sci. USA 91, 3228-3232 (1994). This study established 'proof of principle' that selective inhibition of COX-2 offered the anti-inflammatory activity, but lacked the gastrointestinal side effects of non-selective NSAIDs.
12. Marnett, L. J. & Kalgutkar, A. S. Cyclooxygenase 2 inhibitors: discovery, selectivity and the future. Trends Pharmacol. Sci. 20, 465-469 (1999).
13. Laine, L. et al. A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Gastroenterology 117, 776-783 (1999).
14. Emery, P. et al. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet 354, 2106-2111 (1999).
15. Waddell, W. R. & Loughry, R. W. Sulindac for polyposis of the colon. J. Surg. Oncol. 24, 83-87 (1983). The first clinical observation that NSAIDs could cause the regression of intestinal polyps.
16. Giovannucci, E. et al. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. Intern. Med. 121, 241-246 (1994).
17. Giovannucci, E. et al. Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med. 333, 609-614 (1995).
18. Thun, M. J., Namboodiri, M. M. & Heath, C. W. J. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 325, 1593-1596 (1991). The largest and most widely cited prospective population-based study that identified a correlation between NSAID use and a reduction in the relative risk of colorectal cancer.
19. DuBois, R. N., Giardiello, F. M. & Smalley, W. E. Nonsteroidal anti-inflammatory drugs, eicosanoids and colorectal cancer prevention. Gastroenterology Clinics N. Am. 25, 773-791 (1996).
20. Kinzler, K. W. et al. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 251, 1366-1370 (1991).
21. Labayle, D. et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101, 635-639 (1991).